Literature DB >> 15612029

Correction of the CF defect by curcumin: hypes and disappointments.

Marcus Mall1, Karl Kunzelmann.   

Abstract

Cystic fibrosis (CF), the most-common lethal hereditary disease in the white population, is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The mutation that is most frequently responsible for the disease, DeltaF508, causes misfolding and retention of the CFTR protein in the endoplasmic reticulum. This leads to a series of cellular dysfunctions and results in a multi-organ disease. In a recent report, Egan et al.(1) demonstrated that curcumin, a non-toxic natural product and major constituent of turmeric spice, corrected the CF defects in DeltaF508 CF mice. This paper aroused a lot of attention and hopes were raised that curcumin might produce similar effects in human, giving an efficient treatment for most CF patients. However, skepticism is growing since subsequent studies fail to reproduce these initial exciting results. Thus, although herbal medicines and dietary supplements can be desirable alternatives to classical pharmacological compounds, their efficacy needs careful evaluation both in vivo and ex vivo. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15612029     DOI: 10.1002/bies.20168

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  15 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.

Authors:  Clement Mugabe; Majed Halwani; Ali O Azghani; Robert M Lafrenie; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  The bound states of amphipathic drugs in lipid bilayers: study of curcumin.

Authors:  Yen Sun; Chang-Chun Lee; Wei-Chin Hung; Fang-Yu Chen; Ming-Tao Lee; Huey W Huang
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

4.  Exposure to sodium butyrate leads to functional downregulation of calcium-activated potassium channels in human airway epithelial cells.

Authors:  Jeremy Roy; Eileen M Denovan-Wright; Paul Linsdell; Elizabeth A Cowley
Journal:  Pflugers Arch       Date:  2006-09-19       Impact factor: 3.657

5.  Cystic Fibrosis: The Mechanisms of Pathogenesis of an Inherited Lung Disorder.

Authors:  Mark T Clunes; Richard C Boucher
Journal:  Drug Discov Today Dis Mech       Date:  2007

Review 6.  What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.

Authors:  Marijke Proesmans; François Vermeulen; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2008-04-04       Impact factor: 3.183

7.  Currying favor for the heart.

Authors:  Jonathan A Epstein
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels.

Authors:  Beate Illek; Rosalie Maurisse; Logan Wahler; Karl Kunzelmann; Horst Fischer; Dieter C Gruenert
Journal:  Cell Physiol Biochem       Date:  2008-07-25

Review 9.  Protein homeostasis as a therapeutic target for diseases of protein conformation.

Authors:  Barbara Calamini; Richard I Morimoto
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 10.  Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis.

Authors:  Mark T Clunes; Richard C Boucher
Journal:  Curr Opin Pharmacol       Date:  2008-05-28       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.